Pharmaceutical Stocks in Focus: Eli Lilly, Johnson & Johnson, and More
Five pharmaceutical stocks are on watch today, according to MarketBeat's stock screener tool. These companies had the highest dollar trading volume of any pharmaceutical stocks within the last several days.
Eli Lilly and Company (LLY) is one such company, discovering, developing, and marketing human pharmaceuticals worldwide. It offers various medications for diabetes, type 2 diabetes, and obesity, including Basaglar, Humalog, Jardiance, Mounjaro, Trulicity, and Zepbound.
Johnson & Johnson (JNJ) is another company on the list, operating through its Innovative Medicine and MedTech segments. It focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
A third company, AbbVie (ABBV), discovers, develops, manufactures, and sells pharmaceuticals worldwide. Its products include Humira, Skyrizi, Rinvoq, Imbruvica, Epkinly, Elahere, and Venclexta/Venclyxto.
The FTC is suing Hims & Hers Health due to concerns over misleading advertising claims about its sexual health treatments. However, this lawsuit may benefit Hims & Hers, as it has reportedly dropped obesity drug coverage, which could make Hims & Hers a winner in the market.